ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
MaxCyte Inc

MaxCyte Inc (MXCT)

1,14
-0,09
(-7,32%)
Geschlossen 07 Juni 10:00PM
1,145
0,005
(0,44%)
Nach Börsenschluss: 1:59AM

MaxCyte Inc (MXCT) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
1,14
( -7,32% )
Gebot
0,904
Fragen
1,46
Volumen
900.806
1,14 Tagesbereich 1,23
0,6434 52-Wochen-Bereich 2,40
Marktkapitalisierung
Handelsende
1,23
Handelsbeginn
1,22
Letzte Trade
81
@
1.21
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.065.826
VWAP
1,1832
Durchschnittliches Volumen (3 Mio.)
US$ 1.005.838
Ausgegebene Aktien
107.121.672
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-3,3
Gewinn pro Aktie (EPS)
-0,37
Erlöse (LTM)
32,29M
Nettogewinn (LTM)
-39,12M

Über MaxCyte Inc

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation fo... MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Rockville, United States
Gegründet
1998
MaxCyte Inc is listed in the Healthcare sector of the NASDAQ with ticker MXCT. The last closing price for MaxCyte was US$1,23. Over the last year, MaxCyte shares have traded in a share price range of US$ 0,6434 to US$ 2,40.

MaxCyte currently has 107.121.672 shares in issue. The market capitalisation of MaxCyte is US$122,12 million. MaxCyte has a price to earnings ratio (PE ratio) of -3.30.

MXCT Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.03-2.56410256411.171.2951.13510032361.21709215CS
40.2731.03448275860.871.2950.78413862651.07323876CS
120.30135.87604290820.8391.2950.65939732570.91839539CS
26-0.51-30.90909090911.651.650.643410929661.01596962CS
52-1.25-52.30125523012.392.40.64349360131.31034125CS
156-3.2-73.7327188944.345.5450.64347316382.75941683CS
260-15.85-93.290170688616.9917.440.64346727274.31567746CS

MXCT - Frequently Asked Questions (FAQ)

What is the current MaxCyte Inc share price?
The current share price of MaxCyte Inc is US$ 1,14
How many MaxCyte Inc shares are in issue?
MaxCyte Inc has 107.121.672 shares in issue
What is the market cap of MaxCyte Inc?
The market capitalisation of MaxCyte Inc is USD 122,12M
What is the 1 year trading range for MaxCyte Inc share price?
MaxCyte Inc has traded in the range of US$ 0,6434 to US$ 2,40 during the past year
What is the PE ratio of MaxCyte Inc?
The price to earnings ratio of MaxCyte Inc is -3,3
What is the cash to sales ratio of MaxCyte Inc?
The cash to sales ratio of MaxCyte Inc is 4,01
What is the registered address of MaxCyte Inc?
The registered address for MaxCyte Inc is 9713 Key West Avenue, Rockville, Maryland, 20850
What is the MaxCyte Inc website address?
The website address for MaxCyte Inc is www.maxcyte.com
Which industry sector does MaxCyte Inc operate in?
MaxCyte Inc operates in the Biotechnology & Life Sciences sector

MXCT Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen